Clin2
NCT07203248Likely a fitNot yet recruiting

Real-world study for people with vestibular migraine

Vestibular MigraineDizzinessVertigo

Part of Brain & nervous system, Ear, nose & throat clinical trials.

This study will track how current treatments work for adults with vestibular migraine, a condition where migraine causes dizziness and balance problems. It may help doctors learn which options help most in everyday life.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,000 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You are between 18 and 75 years old.
  • You have been diagnosed with vestibular migraine or probable vestibular migraine by your doctor.
  • You have had at least five episodes of moderate or severe dizziness or balance problems, each lasting 5 minutes to 72 hours.
  • Your dizzy spells often come with migraine headaches, sensitivity to light or sound, or visual aura.
  • You can use an electronic diary to track your symptoms for at least 80% of the time during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07532109Not yet recruiting
Testing a questionnaire for teens with vestibular migraine

This study tests a new questionnaire designed to measure how vestibular migraine (a type of migraine that causes dizziness) affects daily life in teenagers. Participating may help improve how doctors evaluate and support young people with this condition.

Needham, Massachusetts
NCT06748664Not yet recruiting· Phase 2
Rimegepant for vestibular migraine

This trial tests whether rimegepant, a medicine usually used for migraine headaches, can help reduce dizziness attacks in people with vestibular migraine. If you have frequent dizziness and have not found enough relief from other preventive treatments, this study may be an option.

NCT07751497Not yet recruiting· Phase 2
Comparing two medicines to prevent dizziness in vestibular migraine

This study compares two oral medications—rimegepant and flunarizine—to see how well they prevent dizzy or vertigo episodes in people with vestibular migraine. You will take one of the two medicines daily for several months, and track your symptoms on a smartphone app.

Hangzhou, Zhejiang
NCT07655440Not yet recruiting· Phase 4
Comparing migraine prevention options for tinnitus relief

This study tests whether two types of migraine prevention medicines—standard preventive therapies versus newer anti-CGRP treatments—can help reduce tinnitus (ringing or buzzing in the ears) in people who also have migraines. If you have both conditions, this trial may help find a treatment that eases your ear symptoms.

NCT07368140Not yet recruiting
Gentle electrical stimulation for dizziness and migraine

This study tests a new, non-invasive treatment that uses a small electrical device to stimulate the nerves behind the ear. It may help reduce dizziness and migraine symptoms in people who have vestibular migraine, a type of migraine linked to balance problems.

Calgary, Alberta
NCT07871097Recruiting· Phase 4
Rimegepant for acute vestibular migraine relief

This study tests a medication called rimegepant to see if it quickly relieves vertigo and dizziness during a vestibular migraine attack. Vestibular migraine causes symptoms like spinning or imbalance, often with headache. If you have frequent, moderate-to-severe episodes, this treatment might offer relief.

Wuhan, Hubei

Hear when a new Vestibular Migraine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.